Neuroendocrine Tumours Flashcards
What are gastroenteropancreatic Neuroendocrine tumours (GET-NETs )
Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) refers to neuroendrocrine tumours originating from neuroendocrine cells in the tubular gastrointestinal tract and the pancreas
What is the grading classification used for GEP NETs
WHO classification ranging from grade 1 - 3
What is WHO grade 1 for NET
Well differentiated, mitotic count < 2/10 HPF
What are the grade 2 WHO classification for NET
Well differentiated, mitotic count 2-20/10 HPF
What is grade 3 WHO classification for NET
Poorly differentiated, mitotic count > 20 per 10 HPF
What are the risk factors for GEP-NETs
Genetic disorders:
- MEN1
- Von Hippel Lindau
- neurofibromatosis
- tuberous sclerosis complex
What are the clinical features of NETs
Vague abdo pain N+V Abdo distention Bowel obstruction Unintentional weight loss
What is carcinoid syndrome?
Carcinoid syndrome occurs following metastasis of a carcinoid tumour, whereby the metastasised cells begin to oversecrete bioactive mediators, such as serotonin, prostaglandins, and gastrin, into the circulation.
What investigations would you carry out for suspected GEP-NET
Chromogranin A 5-HIAA FBC LFTs Chromogranin B Pancreatic Peptide
For other specific NET such as insulinomas, VIPomas, gastrinomas etc
What is the best imaging modality to assess small bowel NET
CT enterolysis
What is the only curative treatment option available for GEP NETs
Surgery
What is carcinoid crisis
Carcinoid crisis is caused by an overwhelming release of hormones from the NET, resulting in a resistant severe hypotension.
What drugs may be used for the prophylaxis of carcinoid crisis.
Somatostatin analogues may be used for the prophylaxis of carcinoid crisis
What is the management of grade 1 and 2 gastric NETs
Type 1 and type 2 have a very low metastatic potential, therefore can usually be treated with endoscopic resection and annual surveillance
What is the management of grade 3 Gastric NETs
Type 3 are more aggressive lesions, therefore management is often partial or total gastrectomy with lymph node clearance.